Max Healthcare Announces Participation in Investor Conferences
Max Healthcare's Chairman and Senior Management to participate in CLSA 28th India Forum on November 18, 2025, in Mumbai and Goldman Sachs 14th India CIO Tour on November 20, 2025, in New Delhi.
The announcement provides information about investor conferences, which is a routine activity and has a limited impact on the company's value.
The announcement is a routine disclosure about participation in investor conferences.
* Max Healthcare's Chairman, Managing Director, and Senior Management will participate in investor conferences. * CLSA 28th India Forum 2025: November 18, 2025, in Mumbai (Physical, One-on-one & Group Meeting). * Goldman Sachs 14th India CIO Tour: November 20, 2025, in New Delhi (Physical, One-on-one & Group Meeting). * No unpublished price-sensitive information will be shared during these conferences. * Schedule is subject to change.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.